311 related articles for article (PubMed ID: 9557710)
21. Assessment of a cellular vaccination approach consisting of crawling dendritic cells (CDCs) transduced with HSV-1-Deltapac vectors.
Nuñez R; Fraefel C; Suter M; Nuñez-Liman A; Liou HC; Ackerman M
Immunol Res; 2004; 30(1):105-24. PubMed ID: 15258314
[TBL] [Abstract][Full Text] [Related]
22. Early interaction of adeno-associated virus serotype 8 vector with the host immune system following intramuscular delivery results in weak but detectable lymphocyte and dendritic cell transduction.
Gernoux G; Guilbaud M; Dubreil L; Larcher T; Babarit C; Ledevin M; Jaulin N; Planel P; Moullier P; Adjali O
Hum Gene Ther; 2015 Jan; 26(1):1-13. PubMed ID: 25333770
[TBL] [Abstract][Full Text] [Related]
23. Immune responses to viral antigens versus transgene product in the elimination of recombinant adenovirus-infected hepatocytes in vivo.
Yang Y; Jooss KU; Su Q; Ertl HC; Wilson JM
Gene Ther; 1996 Feb; 3(2):137-44. PubMed ID: 8867861
[TBL] [Abstract][Full Text] [Related]
24. Enhanced transduction of mouse bone marrow-derived dendritic cells by repetitive infection with self-complementary adeno-associated virus 6 combined with immunostimulatory ligands.
Aldrich WA; Ren C; White AF; Zhou SZ; Kumar S; Jenkins CB; Shaw DR; Strong TV; Triozzi PL; Ponnazhagan S
Gene Ther; 2006 Jan; 13(1):29-39. PubMed ID: 16136165
[TBL] [Abstract][Full Text] [Related]
25. Differential activation of innate immune responses by adenovirus and adeno-associated virus vectors.
Zaiss AK; Liu Q; Bowen GP; Wong NC; Bartlett JS; Muruve DA
J Virol; 2002 May; 76(9):4580-90. PubMed ID: 11932423
[TBL] [Abstract][Full Text] [Related]
26. The TLR9-MyD88 pathway is critical for adaptive immune responses to adeno-associated virus gene therapy vectors in mice.
Zhu J; Huang X; Yang Y
J Clin Invest; 2009 Aug; 119(8):2388-98. PubMed ID: 19587448
[TBL] [Abstract][Full Text] [Related]
27. CpG-depleted adeno-associated virus vectors evade immune detection.
Faust SM; Bell P; Cutler BJ; Ashley SN; Zhu Y; Rabinowitz JE; Wilson JM
J Clin Invest; 2013 Jul; 123(7):2994-3001. PubMed ID: 23778142
[TBL] [Abstract][Full Text] [Related]
28. Continuous CD8⁺ T-cell priming by dendritic cell cross-presentation of persistent antigen following adeno-associated virus-mediated gene delivery.
Xu D; Walker CM
J Virol; 2011 Nov; 85(22):12083-6. PubMed ID: 21880763
[TBL] [Abstract][Full Text] [Related]
29. In vivo and in vitro modulation of immune stimulatory capacity of primary dendritic cells by adenovirus-mediated gene transduction.
Sonderbye L; Feng S; Yacoubian S; Buehler H; Ahsan N; Mulligan R; Langhoff E
Exp Clin Immunogenet; 1998; 15(2):100-11. PubMed ID: 9691204
[TBL] [Abstract][Full Text] [Related]
30. Cytotoxic T lymphocyte responses to transgene product, not adeno-associated viral capsid protein, limit transgene expression in mice.
Siders WM; Shields J; Kaplan J; Lukason M; Woodworth L; Wadsworth S; Scaria A
Hum Gene Ther; 2009 Jan; 20(1):11-20. PubMed ID: 18828728
[TBL] [Abstract][Full Text] [Related]
31. Cytotoxic T lymphocyte responses to proteins encoded by heterologous transgenes transferred in vivo by adenoviral vectors.
Song W; Kong HL; Traktman P; Crystal RG
Hum Gene Ther; 1997 Jul; 8(10):1207-17. PubMed ID: 9215738
[TBL] [Abstract][Full Text] [Related]
32. Cytotoxic-T-lymphocyte-mediated elimination of target cells transduced with engineered adeno-associated virus type 2 vector in vivo.
Li C; Hirsch M; DiPrimio N; Asokan A; Goudy K; Tisch R; Samulski RJ
J Virol; 2009 Jul; 83(13):6817-24. PubMed ID: 19369348
[TBL] [Abstract][Full Text] [Related]
33. Adenovirus fibre exchange alters cell tropism in vitro but not transgene-specific T CD8+ immune responses in vivo.
Mercier S; Verhaagh S; Goudsmit J; Lemckert A; Monteil M; Havenga M; Eloit M
J Gen Virol; 2004 May; 85(Pt 5):1227-1236. PubMed ID: 15105539
[TBL] [Abstract][Full Text] [Related]
34. Transduction efficiency and immune response associated with the administration of AAV8 vector into dog skeletal muscle.
Ohshima S; Shin JH; Yuasa K; Nishiyama A; Kira J; Okada T; Takeda S
Mol Ther; 2009 Jan; 17(1):73-80. PubMed ID: 18941441
[TBL] [Abstract][Full Text] [Related]
35. Circumventing cellular immunity by miR142-mediated regulation sufficiently supports rAAV-delivered OVA expression without activating humoral immunity.
Xiao Y; Muhuri M; Li S; Qin W; Xu G; Luo L; Li J; Letizia AJ; Wang SK; Chan YK; Wang C; Fuchs SP; Wang D; Su Q; Nahid MA; Church GM; Farzan M; Yang L; Wei Y; Desrosiers RC; Mueller C; Tai PW; Gao G
JCI Insight; 2019 May; 5(13):. PubMed ID: 31112525
[TBL] [Abstract][Full Text] [Related]
36. Gene transfer into hepatocytes mediated by helper virus-free HSV/AAV hybrid vectors.
Fraefel C; Jacoby DR; Lage C; Hilderbrand H; Chou JY; Alt FW; Breakefield XO; Majzoub JA
Mol Med; 1997 Dec; 3(12):813-25. PubMed ID: 9440115
[TBL] [Abstract][Full Text] [Related]
37. Adeno-associated virus vector-mediated gene transfer into dystrophin-deficient skeletal muscles evokes enhanced immune response against the transgene product.
Yuasa K; Sakamoto M; Miyagoe-Suzuki Y; Tanouchi A; Yamamoto H; Li J; Chamberlain JS; Xiao X; Takeda S
Gene Ther; 2002 Dec; 9(23):1576-88. PubMed ID: 12424610
[TBL] [Abstract][Full Text] [Related]
38. Vaccination with helper-dependent adenovirus enhances the generation of transgene-specific CTL.
Harui A; Roth MD; Kiertscher SM; Mitani K; Basak SK
Gene Ther; 2004 Nov; 11(22):1617-26. PubMed ID: 15295617
[TBL] [Abstract][Full Text] [Related]
39. Recombinant adeno-associated virus for muscle directed gene therapy.
Fisher KJ; Jooss K; Alston J; Yang Y; Haecker SE; High K; Pathak R; Raper SE; Wilson JM
Nat Med; 1997 Mar; 3(3):306-12. PubMed ID: 9055858
[TBL] [Abstract][Full Text] [Related]
40. Retrovirally transduced bone marrow-derived dendritic cells require CD4+ T cell help to elicit protective and therapeutic antitumor immunity.
De Veerman M; Heirman C; Van Meirvenne S; Devos S; Corthals J; Moser M; Thielemans K
J Immunol; 1999 Jan; 162(1):144-51. PubMed ID: 9886380
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
